Gisella Guido
Overview
Explore the profile of Gisella Guido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caruso D, De Santis D, Del Gaudio A, Guido G, Zerunian M, Polici M, et al.
Eur Radiol
. 2023 Sep;
34(4):2384-2393.
PMID: 37688618
Objectives: To perform a comprehensive within-subject image quality analysis of abdominal CT examinations reconstructed with DLIR and to evaluate diagnostic accuracy compared to the routinely applied adaptive statistical iterative reconstruction...
2.
Polidori T, De Santis D, Rucci C, Tremamunno G, Piccinni G, Pugliese L, et al.
Radiol Med
. 2023 Jun;
128(8):922-933.
PMID: 37326780
Radiomics is a new emerging field that includes extraction of metrics and quantification of so-called radiomic features from medical images. The growing importance of radiomics applied to oncology in improving...
3.
De Santis D, Polidori T, Tremamunno G, Rucci C, Piccinni G, Zerunian M, et al.
Radiol Med
. 2023 Feb;
128(4):434-444.
PMID: 36847992
Purpose: To perform a comprehensive intraindividual objective and subjective image quality evaluation of coronary CT angiography (CCTA) reconstructed with deep learning image reconstruction (DLIR) and to assess correlation with routinely...
4.
Guido G, Polici M, Nacci I, Bozzi F, De Santis D, Ubaldi N, et al.
J Comput Assist Tomogr
. 2023 Feb;
47(2):244-254.
PMID: 36728734
Image reconstruction processing in computed tomography (CT) has evolved tremendously since its creation, succeeding at optimizing radiation dose while maintaining adequate image quality. Computed tomography vendors have developed and implemented...
5.
Zerunian M, Pucciarelli F, Masci B, Siciliano F, Polici M, Bracci B, et al.
Biomed Res Int
. 2023 Jan;
2022:1147111.
PMID: 36619303
Diffuse liver diseases are highly prevalent conditions around the world, including pathological liver changes that occur when hepatocytes are damaged and liver function declines, often leading to a chronic condition....
6.
Bracci B, De Santis D, Del Gaudio A, Faugno M, Romano A, Tarallo M, et al.
Diagnostics (Basel)
. 2022 Sep;
12(9).
PMID: 36140572
Adrenal lesions are frequently incidentally diagnosed during investigations for other clinical conditions. Despite being usually benign, nonfunctioning, and silent, they can occasionally cause discomfort or be responsible for various clinical...
7.
Zerunian M, Pucciarelli F, Caruso D, Polici M, Masci B, Guido G, et al.
Radiol Med
. 2022 Sep;
127(10):1098-1105.
PMID: 36070066
Purpose: To compare liver MRI with AIR Recon Deep Learning™(ARDL) algorithm applied and turned-off (NON-DL) with conventional high-resolution acquisition (NAÏVE) sequences, in terms of quantitative and qualitative image analysis and...
8.
Thattaamuriyil Padmakumari L, Guido G, Caruso D, Nacci I, Del Gaudio A, Zerunian M, et al.
Diagnostics (Basel)
. 2022 Mar;
12(3).
PMID: 35328296
In many low-income countries, the poor availability of lung biopsy leads to delayed diagnosis of lung cancer (LC), which can appear radiologically similar to tuberculosis (TB). To assess the ability...
9.
Caruso D, Zerunian M, Polici M, Pucciarelli F, Guido G, Polidori T, et al.
Radiol Med
. 2022 Feb;
127(3):309-317.
PMID: 35157241
Purpose: Lung severity score (LSS) and quantitative chest CT (QCCT) analysis could have a relevant impact to stratify patients affected by COVID-19 pneumonia at the hospital admission. The study aims...
10.
Caruso D, Zerunian M, Pucciarelli F, Lucertini E, Bracci B, Polidori T, et al.
BJR Open
. 2021 Aug;
2(1):20200052.
PMID: 34381937
Coronavirus disease 2019 (COVID-19) is a respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first described in Wuhan, Hubei Province, China in the last months of 2019...